Gov’t starts researching generic drug pricing policy in 2H

By Lee, Jeong-Hwan | translator Kim, Jung-Ju

23.07.11 12:10:53

가나다라 0

Evaluates the feasibility of the price cut criteria of ‘20 listed generics’ and price cut rate of ’53.55%’ after patent expiry

Evaluate generic drug price system and level at 8 overseas countries including Japan, France, and Germany

Gov't “Too many generics are still being released even after the implementation of the stepped pricing system in July”

The Ministry of Health and Welfare has started research to improve the generic drug price system in the second half of this year. The industry expects that the authorities will likely prepare and implement a system to reduce the price of generic drugs as soon as the research is complete.

The research will mainly investigate the need to change the ’20 listed drugs’ standard used to differentiate the drug price of same-ingredient drugs and the 53.55% generic drug price discount rate that is applied after the expiry of the original drug’s patent.

Recently, the Ministry of Health and Welfare signed a private contract with Professor Dong-sook Kim’s research team at Kongju National Univers

Lee, Jeong-Hwan(junghwanss@dailypharm.com)

If you want to see the full article, please JOIN US (click)